We are live on
!
Find out more
DZ Bank Portfolio holdings
AUM
$113B
1-Year Est. Return
36.92%
This Fund
S&P 500
This Quarter
Est. Return
+4.03%
1 Year Est. Return
+36.92%
3 Year Est. Return
+150.91%
5 Year Est. Return
+223.96%
10 Year Est. Return
–
AUM
$27.1B
AUM Growth
+$1.26B
(+4.9%)
Cap. Flow
-$1.1B
Cap. Flow
% of AUM
-4.07%
Top 10 Holdings %
Top 10 Hldgs %
19.33%
Holding
1,220
New
87
Increased
242
Reduced
333
Closed
370
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class A
BRK.A
|
+$162M |
| 2 |
UnitedHealth
UNH
|
+$153M |
| 3 |
Honeywell
HON
|
+$152M |
| 4 |
Nutrien
NTR
|
+$135M |
| 5 |
Deere & Co
DE
|
+$121M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
3M
MMM
|
+$261M |
| 2 |
Capri Holdings
CPRI
|
+$89.4M |
| 3 |
TWX
Time Warner Inc
TWX
|
+$88.2M |
| 4 |
Citigroup
C
|
+$86.2M |
| 5 |
Goldman Sachs
GS
|
+$83.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 21.28% |
| 2 | Technology | 14.24% |
| 3 | Healthcare | 13.49% |
| 4 | Consumer Discretionary | 11.17% |
| 5 | Communication Services | 8.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
926
Neurocrine Biosciences
NBIX
$17.9B
| – | – |
-60,700
| Closed | -$5.03M |
|
927
Nordson
NDSN
$16.5B
| – | – |
-4,140
| Closed | -$564K |
|
928
Enpro
NPO
$6.92B
| – | – |
-73
| Closed | -$6K |
|
929
Insperity
NSP
$1.91B
| – | – |
-12,116
| Closed | -$843K |
|
930
Northern Trust
NTRS
$22.2B
| – | – |
-1,790
| Closed | -$185K |
|
931
Ocugen
OCGN
$427M
| – | – |
-1,377
| Closed | -$227K |
|
932
Old Dominion Freight Line
ODFL
$47.4B
| – | – |
-339
| Closed | -$16K |
|
|
ODP
933
DELISTED
ODP
ODP
| – | – |
-4,600
| Closed | -$99K |
|
934
Oneok
OKE
$57.2B
| – | – |
-4,024
| Closed | -$229K |
|
935
ON Semiconductor
ON
$33.3B
| – | – |
-14,329
| Closed | -$350K |
|
936
Opko Health
OPK
$929M
| – | – |
-219,000
| Closed | -$694K |
|
937
OR Royalties Inc
OR
$5.42B
| – | – |
-252,431
| Closed | -$2.43M |
|
938
O'Reilly Automotive
ORLY
$74.9B
| – | – |
-57,750
| Closed | -$953K |
|
939
Plains All American Pipeline
PAA
$17.2B
| – | – |
-9,000
| Closed | -$198K |
|
940
Paycom
PAYC
$7.12B
| – | – |
-11,200
| Closed | -$1.2M |
|
|
PCH
941
DELISTED
PotlatchDeltic
PCH
| – | – |
-4,646
| Closed | -$242K |
|
942
Paylocity
PCTY
$7.01B
| – | – |
-21,350
| Closed | -$1.09M |
|
943
Precigen
PGEN
$1.99B
| – | – |
-71,000
| Closed | -$1.09M |
|
944
Progressive
PGR
$125B
| – | – |
-5,998
| Closed | -$365K |
|
|
PINC
945
DELISTED
Premier
PINC
| – | – |
-157,322
| Closed | -$4.92M |
|
946
Protalix BioTherapeutics
PLX
$197M
| – | – |
-34,650
| Closed | -$187K |
|
947
Pilgrim's Pride
PPC
$6.96B
| – | – |
-234
| Closed | -$6K |
|
948
Primoris Services
PRIM
$4.56B
| – | – |
-461
| Closed | -$11K |
|
949
Protolabs
PRLB
$1.86B
| – | – |
-96
| Closed | -$12K |
|
950
Protagonist Therapeutics
PTGX
$8.86B
| – | – |
-13,100
| Closed | -$113K |
|
Similar funds
VAM
DZ Bank's Q2 2018 Portfolio in Review
As of Q2 2018, DZ Bank held 1,220 positions worth $27.1B, up 4.9% from $25.8B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
DZ Bank withdrew a net $1.1B in Q2 2018, closing 370 positions and reducing 333 holdings. Its most notable exit was Time Warner Inc, an estimated $88.2M position sold in full.
By sector, the portfolio is most concentrated in Financials at 21% of assets, down from 22% a quarter earlier, followed by Technology and Healthcare.
Against the trend, DZ Bank opened a new position in OAKTREE CAPITAL GROUP, LLC worth $17.4M.
- DZ Bank's largest Q2 2018 buy was OAKTREE CAPITAL GROUP, LLC: 428,064 shares worth $17.4M.
- DZ Bank added most to Berkshire Hathaway Class A in Q2 2018, an estimated $162M increase.
- DZ Bank's biggest Q2 2018 reduction was 3M, cutting an estimated $261M.
- DZ Bank fully exited Time Warner Inc in Q2 2018, selling an estimated $88.2M.
- DZ Bank's ten largest holdings make up 19% of its $27.1B portfolio in Q2 2018.
- DZ Bank opened 87 new positions and closed 370 in Q2 2018.
- DZ Bank's portfolio value rose 4.9% quarter-over-quarter to $27.1B.
Based on DZ Bank's 13F filing for Q2 2018, filed 14 Aug 2018.